PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 9:53 AM ET

Sponsor Check › Person

AE
No photo found yet (own website and image search run after this page is viewed)

Anthony Evnin

Named as an officer, director or promoter on SEC Form D filings · MA · Apr 1, 2009 → Oct 8, 2019

4deals (issuers)
$268.8Mreported sold
100investors
16Form D filings
2009–2019years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:19 AM ET · SEC enforcement last checked: Oct 24, 2026, 12:37 AM ET

The short version

Anthony Evnin is listed as a director on 16 SEC Form D filings by 4 issuers between Apr 2009 and Oct 2019: CONSTELLATION PHARMACEUTICALS INC (Cambridge, MA — biotechnology — 2010–2019; $99M reported sold to 30 investors), INFINITY PHARMACEUTICALS, INC. (Cambridge, MA — biotechnology — 2012; $78.5M reported sold to 1 investors), AVEO PHARMACEUTICALS INC (Cambridge, MA — pharmaceuticals — 2009–2011; $60.8M reported sold to 21 investors) and ACCELERON PHARMA INC (Cambridge, MA — biotechnology — 2009–2013; $30.5M reported sold to 48 investors).

What this means A repeat sponsor — 4 separate companies raised money with this person listed as director, over about 10 years. Across those companies the filings report $268.8M sold in total.

Listed alongside TOM MANIATIS (10 shared filings), Mark Goldsmith (7 shared filings), Robert Tepper (7 shared filings), James E. Audia (6 shared filings), JOHN KNOPF (5 shared filings) and 67 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Anthony. Each name links to their own page.

1 of the issuers belongs to the sponsor group Third Rock (7 issuers, $2.62B reported sold, 2010–2026).

What this means A sponsor group is one team that sets up a new company for each deal. Third Rock has 7 companies on file and $2.62B reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — none found.

What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.

We compared 16 public filings for Anthony Evnin and found 13 differences, 3 worth asking the sponsor about: Regulator action naming a team member: AVEO Pharmaceuticals, Inc., et al. (Apr 4, 2019); Regulator action naming a team member: AVEO Pharmaceuticals, Inc., et al. (Mar 5, 2018); and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Anthony Evnin has not run yet — it is joining a line of 42,857 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:19 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (checked Oct 24, 2026) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases + SEC administrative proceedings (sec.gov index, 1995-09-19 → 2026-10-23) — last checked Oct 24, 2026, 12:37 AM ET.

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

None found in sources searched — federal bankruptcy courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:19 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

13 differences found between the filings for Anthony Evnin — 3 worth asking about (compared 16 filings on Oct 24, 2026)

Worth asking · Apr 4, 2019

Regulator action naming a team member: AVEO Pharmaceuticals, Inc., et al. (Apr 4, 2019)

An SEC litigation release dated Apr 4, 2019 names AVEO PHARMACEUTICALS INC (related issuer). The release is the source; we do not summarize its outcome here.

What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.

AVEO Pharmaceuticals, Inc., et al. ↗AVEO PHARMACEUTICALS INC — PartnerFacts page ↗
Sources
Worth asking · Mar 5, 2018

Regulator action naming a team member: AVEO Pharmaceuticals, Inc., et al. (Mar 5, 2018)

An SEC litigation release dated Mar 5, 2018 names AVEO PHARMACEUTICALS INC (related issuer). The release is the source; we do not summarize its outcome here.

What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.

AVEO Pharmaceuticals, Inc., et al. ↗AVEO PHARMACEUTICALS INC — PartnerFacts page ↗
Sources
Worth asking · Mar 29, 2016

Regulator action naming a team member: AVEO Pharmaceuticals, Inc., et al. (Mar 29, 2016)

An SEC litigation release dated Mar 29, 2016 names AVEO PHARMACEUTICALS INC (related issuer). The release is the source; we do not summarize its outcome here.

What this means A regulator filed or announced an action naming this person or company (or someone on the same filings). Read the release; ask the sponsor what it was and how it ended.

AVEO Pharmaceuticals, Inc., et al. ↗AVEO PHARMACEUTICALS INC — PartnerFacts page ↗
Sources
Note · May 14, 2001 – Aug 15, 2001

Bankruptcy case: Chase Manhattan Bank USA NA v. Maniatis — filed May 14, 2001

United States Bankruptcy Court, E.D. New York docket "Chase Manhattan Bank USA NA v. Maniatis" filed May 14, 2001, closed Aug 15, 2001. TOM MANIATIS (listed on the same filings) is listed as Defendant ("Maniatis"). Our match estimate: 70%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, E.D. New York ↗TOM MANIATIS — PartnerFacts page ↗
Sources
Note · Sep 7, 2012 – Sep 24, 2012

Form D filed 17 days after the first sale — INFINITY PHARMACEUTICALS, INC.

The filing says the first sale was Sep 7, 2012. The Form D was filed Sep 24, 2012 — 17 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 2 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Sep 24, 2012 ↗INFINITY PHARMACEUTICALS, INC. — PartnerFacts page ↗
Sources
Note · Mar 22, 2018 – Apr 6, 2018

No amendment in the last 12 months on an offering that may still be open — CONSTELLATION PHARMACEUTICALS INC (latest filing Apr 6, 2018)

The latest filing for this offering is dated Apr 6, 2018 (first sale Mar 22, 2018). It reports $99,000,000 sold of $100,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Apr 6, 2018 ↗CONSTELLATION PHARMACEUTICALS INC — PartnerFacts page ↗
Sources
Note · Jun 10, 2010 – Jul 21, 2010

No amendment in the last 12 months on an offering that may still be open — ACCELERON PHARMA INC (latest filing Jul 21, 2010)

The latest filing for this offering is dated Jul 21, 2010 (first sale Jun 10, 2010). It reports $10,250,006 sold of $11,500,005 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D/A · Jul 21, 2010 ↗ACCELERON PHARMA INC — PartnerFacts page ↗
Sources
Note · Mar 18, 2009 – Apr 1, 2009

No amendment in the last 12 months on an offering that may still be open — AVEO PHARMACEUTICALS INC (latest filing Apr 1, 2009)

The latest filing for this offering is dated Apr 1, 2009 (first sale Mar 18, 2009). It reports $30,000,000 sold of $60,000,000 offered. No later amendment is in our index as of Oct 24, 2026.

What this means SEC rules expect a yearly amendment while an offering is still going. The raise may simply have ended — a Form D does not say when it closed. Ask the sponsor whether the offering closed, when, and at what amount.

Form D · Apr 1, 2009 ↗AVEO PHARMACEUTICALS INC — PartnerFacts page ↗
Sources
Note · Apr 1, 2009 – Jan 4, 2012

Anthony Evnin is written 2 different ways on the filings

listed as "Anthony Evnin" on 13 filings (from Apr 1, 2009), and "Anthony B Evnin" on 3 filings (from Jan 4, 2012).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Apr 1, 2009 ↗Form D · Jan 4, 2012 ↗Anthony Evnin — PartnerFacts page ↗
Sources
Note · Apr 1, 2009 – Nov 3, 2010

Industry group changed between filings — AVEO PHARMACEUTICALS INC

"Other" (Apr 1, 2009); then "Pharmaceuticals" (Nov 3, 2010 to May 31, 2011).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Apr 1, 2009 ↗Form D · Nov 3, 2010 ↗AVEO PHARMACEUTICALS INC — PartnerFacts page ↗
Sources
Note · May 8, 2014 – Oct 5, 2017

Same name, different state: "Anthony Evnin" (WA) is a separate record

This page covers filings where the address state is MA. A separate record, "Anthony Evnin" with address state WA, is listed on 6 filings — most recently by Juno Therapeutics, Inc. (Oct 5, 2017). Both records have filings in the same period (May 8, 2014 to Oct 5, 2017).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Anthony Evnin (WA) — PartnerFacts page ↗Form D · Oct 5, 2017 ↗Juno Therapeutics, Inc. — PartnerFacts page ↗Anthony Evnin (MA) — this page ↗
Sources
Note · Sep 10, 2009 – Dec 22, 2011

Same name, different state: "Anthony B. Evnin" (NY) is a separate record

This page covers filings where the address state is MA. A separate record, "Anthony B. Evnin" with address state NY, is listed on 8 filings — most recently by Eiger BioPharmaceuticals, Inc. (Dec 22, 2011). Both records have filings in the same period (Sep 10, 2009 to Dec 22, 2011).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Anthony B. Evnin (NY) — PartnerFacts page ↗Form D · Dec 22, 2011 ↗Eiger BioPharmaceuticals, Inc. — PartnerFacts page ↗Anthony Evnin (MA) — this page ↗
Sources
Note · Jul 21, 2009 – Oct 25, 2010

Same name, different state: "Anthony Evnin" (GA or NY) is a separate record

This page covers filings where the address state is MA. A separate record, "Anthony Evnin" with address state GA or NY, is listed on 6 filings — most recently by Altea Therapeutics Corp (Oct 25, 2010). Both records have filings in the same period (Jul 21, 2009 to Oct 25, 2010).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Anthony Evnin (GA,NY) — PartnerFacts page ↗Form D · Oct 25, 2010 ↗Altea Therapeutics Corp — PartnerFacts page ↗Anthony Evnin (MA) — this page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

1 of 15 offerings reports sales commissions totalling $3,645,000; 0 report finder's fees; 0 report proceeds to related persons.

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Oct 8, 2019 D
CONSTELLATION PHARMACEUTICALS INC
File 021-350552
$0$0$0None listed on this filingEDGAR ↗
Apr 6, 2018 D
CONSTELLATION PHARMACEUTICALS INC
File 021-309534
$0$0$0None listed on this filingEDGAR ↗
Sep 27, 2016 D
CONSTELLATION PHARMACEUTICALS INC
File 021-271333
$0$0$0None listed on this filingEDGAR ↗
Dec 15, 2015 D
CONSTELLATION PHARMACEUTICALS INC
File 021-253071
$0$0$0None listed on this filingEDGAR ↗
Aug 5, 2014 D
CONSTELLATION PHARMACEUTICALS INC
File 021-222326
$0$0$0None listed on this filingEDGAR ↗
Sep 27, 2013 D
ACCELERON PHARMA INC
File 021-203637
$0$0$0None listed on this filingEDGAR ↗
Sep 24, 2012 D
INFINITY PHARMACEUTICALS, INC.
File 021-184502
$0$0$0None listed on this filingEDGAR ↗
Jan 4, 2012 D
ACCELERON PHARMA INC
File 021-171126
$0$0$0None listed on this filingEDGAR ↗
Jun 6, 2011 D
CONSTELLATION PHARMACEUTICALS INC
File 021-160851
$0$0$0None listed on this filingEDGAR ↗
May 31, 2011 D
AVEO PHARMACEUTICALS INC
File 021-160532
$0$0$0None listed on this filingEDGAR ↗
Nov 3, 2010 D
AVEO PHARMACEUTICALS INC
File 021-149990
$3,645,000$0$0J.P. Morgan Securities LLC BrokerCheck CRD 79 ↗
Canaccord Genuity Inc. BrokerCheck CRD 1020 ↗
RBC Capital Markets Corporation BrokerCheck CRD 31194 ↗		EDGAR ↗
Jul 21, 2010 D/A
ACCELERON PHARMA INC
File 021-143718
$0$0$0None listed on this filingEDGAR ↗
Jun 2, 2010 D
CONSTELLATION PHARMACEUTICALS INC
File 021-142827
$0$0$0None listed on this filingEDGAR ↗
Dec 15, 2009 D
ACCELERON PHARMA INC
File 021-63019
$0$0$0None listed on this filingEDGAR ↗
Apr 1, 2009 D
AVEO PHARMACEUTICALS INC
File 021-76653
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 4

Every issuer that named Anthony Evnin on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

CP
Biotechnology · group: Third Rock

CONSTELLATION PHARMACEUTICALS INC

Cambridge, MA · Jun 2, 2010 → Oct 8, 2019 · 7 filings
  • Oct 8, 2019 · D · $64,999,985 sold of $64,999,985 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 6, 2018 · D · $99,000,000 sold of $100,000,000 · 30 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 27, 2016 · D · $24,298,209 sold of $24,298,209 · 17 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 15, 2015 · D · $55,824,208 sold of $55,824,208 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 5, 2014 · D · $5,000,000 sold of $5,000,000 · 8 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 6, 2011 · D · $15,000,000 sold of $15,000,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 2, 2010 · D · $22,250,000 sold of $22,250,000 · 9 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $99M from 30 investors (100% of the $65M target) as of the latest filing. Anthony is listed as director on 7 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AP
Biotechnology

ACCELERON PHARMA INC

Cambridge, MA · Dec 15, 2009 → Sep 27, 2013 · 5 filings
  • Sep 27, 2013 · D · $10,000,005 sold of $10,000,005 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 4, 2012 · D · $30,472,934 sold of $30,472,934 · 47 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 21, 2010 · D/A · $10,250,006 sold of $11,500,005 · 48 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 18, 2010 · D · $8,355,421 sold of $11,500,005 · 38 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 15, 2009 · D · $10,951,121 sold of $10,951,121 · 40 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $30.5M from 48 investors (100% of the $10M target) as of the latest filing. Anthony is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

IP
Biotechnology

INFINITY PHARMACEUTICALS, INC.

Cambridge, MA · Sep 24, 2012
  • Sep 24, 2012 · D · $78,540,191 sold of $78,540,191 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $78.5M from 1 investor (100% of the $78.5M target) as of the latest filing. Anthony is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

AP
Pharmaceuticals

AVEO PHARMACEUTICALS INC

Cambridge, MA · Apr 1, 2009 → May 31, 2011 · 3 filings
  • May 31, 2011 · D · $7,499,997 sold of $7,499,997 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 3, 2010 · D · $60,750,000 sold of $60,750,000 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 1, 2009 · D · $30,000,000 sold of $60,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $60.8M from 21 investors (100% of the $7.5M target) as of the latest filing. Anthony is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (3)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Anthony Evnin — GA, NY, 3 issuers, Jul 21, 2009 → Oct 25, 2010 · no shared issuer
  • Anthony B. Evnin — NY, 1 issuer, Sep 10, 2009 → Dec 22, 2011 · no shared issuer
  • Anthony Evnin — WA, 1 issuer, May 8, 2014 → Oct 5, 2017 · no shared issuer

People around Anthony 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

TM
No photo found yet (own website and image search run after this page is viewed)
Person

TOM MANIATIS

Director · 10 shared filings (2 issuers) · also on 1 other issuer

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

RT
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Tepper

Director · 7 shared filings (1 issuer) · also on 14 other issuers

Robert Tepper is on 15 issuers in total — a repeat sponsor. Their page lists every one.

MG
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Goldsmith

Executive Officer, Director · 7 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

JA
No photo found yet (own website and image search run after this page is viewed)
Person

James E. Audia

Executive Officer, Director · 6 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

JG
No photo found yet (own website and image search run after this page is viewed)
Person

Jean George

Director · 5 shared filings (1 issuer) · also on 11 other issuers

Jean George is on 12 issuers in total — a repeat sponsor. Their page lists every one.

RP
No photo found yet (own website and image search run after this page is viewed)
Person

RICHARD POPS

Director · 5 shared filings (1 issuer)

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

JK
No photo found yet (own website and image search run after this page is viewed)
Person

JOHN KNOPF

Executive Officer, Director · 5 shared filings (1 issuer)

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

MATTHEW L. SHERMAN

Executive Officer · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Carl L. Gordon

Director · 4 shared filings (1 issuer) · also on 61 other issuers

Carl L. Gordon is on 62 issuers in total — a repeat sponsor. Their page lists every one.

DG
No photo found yet (own website and image search run after this page is viewed)
Person

David Goeddel

Director · 4 shared filings (1 issuer) · also on 19 other issuers

David Goeddel is on 20 issuers in total — a repeat sponsor. Their page lists every one.

WV
No photo found yet (own website and image search run after this page is viewed)
Person

WYLIE VALE

Director · 4 shared filings (1 issuer)

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

MC
No photo found yet (own website and image search run after this page is viewed)
Person

Michael R. Cooper

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

NG
No photo found yet (own website and image search run after this page is viewed)
Person

Nicholas Galakatos

Director · 3 shared filings (1 issuer) · also on 31 other issuers

Nicholas Galakatos is on 32 issuers in total — a repeat sponsor. Their page lists every one.

RH
No photo found yet (own website and image search run after this page is viewed)
Person

Russell Hirsch

Director · 3 shared filings (1 issuer) · also on 11 other issuers

Russell Hirsch is on 12 issuers in total — a repeat sponsor. Their page lists every one.

RK
No photo found yet (own website and image search run after this page is viewed)
Person

Raju Kucherlapati

Director · 3 shared filings (1 issuer) · also on 5 other issuers

Raju Kucherlapati is on 6 issuers in total — a repeat sponsor. Their page lists every one.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

Douglas Cole

Director · 3 shared filings (1 issuer) · also on 8 other issuers

Douglas Cole is on 9 issuers in total — a repeat sponsor. Their page lists every one.

KW
No photo found yet (own website and image search run after this page is viewed)
Person

Kenneth E. Weg

Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

RD
No photo found yet (own website and image search run after this page is viewed)
Person

Ronald DePinho

Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

TN
No photo found yet (own website and image search run after this page is viewed)
Person

Tuan Ha-Ngoc

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

TM
No photo found yet (own website and image search run after this page is viewed)
Person

TERRY MCGUIRE

Director · 3 shared filings (1 issuer) · also on 9 other issuers

TERRY MCGUIRE is on 10 issuers in total — a repeat sponsor. Their page lists every one.

EK
No photo found yet (own website and image search run after this page is viewed)
Person

Ed Kania

Director · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

PG
No photo found yet (own website and image search run after this page is viewed)
Person

PAT GAGE

Director · 3 shared filings (1 issuer)

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

PC
No photo found yet (own website and image search run after this page is viewed)
Person

PETER COUROSSI

Executive Officer · 3 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

MJ
No photo found yet (own website and image search run after this page is viewed)
Person

Matthias Jaffe

Executive Officer · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Jasbir S. Seehra

Executive Officer · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

JR
No photo found yet (own website and image search run after this page is viewed)
Person

Jigar Raythatha

Executive Officer, Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

TM
No photo found yet (own website and image search run after this page is viewed)
Person

Terrance McGuire

Director · 2 shared filings (1 issuer) · also on 20 other issuers

Terrance McGuire is on 21 issuers in total — a repeat sponsor. Their page lists every one.

JZ
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph S. Zakrzewski

Director · 2 shared filings (1 issuer) · also on 6 other issuers

Joseph S. Zakrzewski is on 7 issuers in total — a repeat sponsor. Their page lists every one.

EK
No photo found yet (own website and image search run after this page is viewed)
Person

Edwin M. Kania, Jr.

Director · 2 shared filings (1 issuer) · also on 5 other issuers

Edwin M. Kania, Jr. is on 6 issuers in total — a repeat sponsor. Their page lists every one.

ML
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Levin

Director · 2 shared filings (1 issuer) · also on 8 other issuers

Mark Levin is on 9 issuers in total — a repeat sponsor. Their page lists every one.

GB
No photo found yet (own website and image search run after this page is viewed)
Person

Garen Bohlin

Executive Officer · 2 shared filings (1 issuer) · also on 6 other issuers

Garen Bohlin is on 7 issuers in total — a repeat sponsor. Their page lists every one.

KD
No photo found yet (own website and image search run after this page is viewed)
Person

Keith Dionne

Executive Officer, Director · 2 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

DJ
No photo found yet (own website and image search run after this page is viewed)
Person

David Johnston

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

RY
No photo found yet (own website and image search run after this page is viewed)
Person

Robert C. Young

Director · 2 shared filings (1 issuer)

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

KB
No photo found yet (own website and image search run after this page is viewed)
Person

Kenneth Bate

Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

WS
No photo found yet (own website and image search run after this page is viewed)
Person

William Slichenmyer

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

JG
No photo found yet (own website and image search run after this page is viewed)
Person

Jeno Gyuris

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

SP
No photo found yet (own website and image search run after this page is viewed)
Person

Steven Paul

Director · 2 shared filings (1 issuer) · also on 5 other issuers

Steven Paul is on 6 issuers in total — a repeat sponsor. Their page lists every one.

SE
No photo found yet (own website and image search run after this page is viewed)
Person

STEVEN ERTEL

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

ROBERT STEININGER

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Anthony Evnin. Their page shows their other deals.

The team behind the deals

TR
Sponsor group

Third Rock

7 issuers · 15 filings · $2.62B reported sold · 2010–2026

One team, 7 deal companies. Anthony Evnin is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Anthony Evnin.

Same business address

10 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 4 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Anthony Evnin by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 4 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Anthony Evnin is listed on: none on file. No website or social profile named in INFINITY PHARMACEUTICALS, INC.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #337,136 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Cambridge, MA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗Massachusetts MassCourts ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

Massachusetts Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Anthony Evnin appears on a new Form D, or when a court case or SEC action is matched to them. See plans →